Mutations in the von Willebrand factor gene responsible for von Willebrand
disease, in particular those responsible for type 2 von Willebrand disease,
are being increasingly identified. The plethora of mutation screening tech
niques now available and their enhanced sample throughput capability is als
o enabling an increasing number of investigations in patients with types 1
and 3 disease. An unambiguous von Willebrand factor nucleotide and amino ac
id nomenclature is now essential. In this paper, we present a uniform stand
ard nomenclature for von Willebrand factor gene mutations and polymorphisms
as approved and recommended by the International Society on Thrombosis and
Haemostasis Scientific and Standardisation Committee subcommittee on von W
illebrand factor.